XML 56 R46.htm IDEA: XBRL DOCUMENT
v3.25.1

BUSINESS COMBINATION - Narrative (Details) |  | 3 Months Ended | 7 Months Ended | 12 Months Ended
--- | --- | --- | --- | ---
Sep. 16, 2024 USD ($) contingentValueRight $ / shares | Mar. 31, 2025 USD ($) | Mar. 31, 2024 USD ($) | Mar. 31, 2025 USD ($) | Dec. 31, 2024 USD ($)
Business Acquisition [Line Items] |  |  |  |  |
Selling, general and administrative expenses |  | $ 76,528,000 | $ 48,021,000 |  |
Research and development expense |  | 10,564,000 | 10,511,000 |  |
Alimera Sciences, Inc |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Common Stock, par value (in dollars per share) | $ / shares | $ 0.01 |  |  |  |
Cash consideration per share (in dollars per share) | $ / shares | $ 5.50 |  |  |  |
Business combination, number of contingent value rights to be received | contingentValueRight | 1 |  |  |  |
Repayment of Alimera Debt | $ 78,540,000 |  |  |  |
Payment of Alimera transaction costs | 20,172,000 |  |  |  |
Payment of settlement of acquiree's equity awards | 19,300,000 |  |  |  |
Cash paid at closing for settlement of equity awards | 1,300,000 |  |  |  |
Cash settlement for pre-acquisition equity awards | 9,535,000 |  |  |  |
Selling, general and administrative expenses |  |  |  |  | $ 8,800,000
Research and development expense |  |  |  |  | $ 1,000,000.0
Fair value of CVRs | 8,322,000 |  |  |  |
Business combination, contingent value rights | $ 8,700,000 |  |  |  |
Goodwill decrease on adjustment |  | 200,000 |  | $ 235,000 |
Payment of Alimera transaction costs |  | 900,000 | $ 0 |  |
Alimera Sciences, Inc | Contingent Value Right |  |  |  |  |
Business Acquisition [Line Items] |  |  |  |  |
Selling, general and administrative expenses |  | $ 400,000 |  |  |

X
- Definition Business Combination, Consideration Transferred, Acquiree's Acquisition Costs + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredAcquireesAcquisitionCosts
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Consideration Transferred, Contingent Value Right Per Acquiree Share + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredContingentValueRightPerAcquireeShare
Namespace Prefix: | anip_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Consideration Transferred, Contingent Value Rights + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredContingentValueRights
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Cash Paid Per Acquiree Share + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableCashPaidPerAcquireeShare
Namespace Prefix: | anip_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Business Combination, Consideration Transferred, Settlement Of Acquiree's Equity Awards + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredSettlementOfAcquireesEquityAwards
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Consideration Transferred, Settlement Of Pre-Acquisition Equity Awards + References No definition available. + Details
Name: | anip_BusinessCombinationConsiderationTransferredSettlementOfPreAcquisitionEquityAwards
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Business Combination, Contingent Value Rights + References No definition available. + Details
Name: | anip_BusinessCombinationContingentValueRights
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Payments For Settlement Of Acquiree's Equity Awards + References No definition available. + Details
Name: | anip_PaymentsForSettlementOfAcquireesEquityAwards
Namespace Prefix: | anip_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5 + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 25 -Paragraph 23 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479405/805-10-25-23 + Details
Name: | us-gaap_BusinessCombinationAcquisitionRelatedCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 25 -Paragraph 16 -SubTopic 10 -Topic 805 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479405/805-10-25-16 + Details
Name: | us-gaap_GoodwillPurchaseAccountingAdjustments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 15 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_RepaymentsOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1 + Details
Name: | us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=anip_AlimeraSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ContingentConsiderationByTypeAxis=anip_ContingentValueRightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |